Ribobay Pharma News and Resources

Ribobay Pharma, a Chinese biopharmaceutical contract research, development, and manufacturing organisation (CRDMO), has announced its collaboration with Cytiva. The company has adopted Cytiva’s first FlexFactory platform for oligonucleotide (oligo) manufacturing, marking a significant step in providing cGMP-level oligo CRDMO services